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ARTICLE
Everyday characterizations of translational
research: researchers’ own use of terminology
and models in medical research and practice
Dixi Louise Strand 1,2✉
ABSTRACT Biomedical literature and policy are highly concerned with encouraging and
improving the clinical application and clinical benefit of new scientific knowledge. Debates,
theorizing, and policy initiatives aiming to close the “bench-to-bedside gap” have led to the
development of “Translational Research” (TR), an emerging set of research-related dis-
courses and practices within biomedicine. Studies in social science and the humanities have
explored and challenged the assumptions underpinning specific TR models and policy
initiatives, as well as the socio-material transformations involved. However, only few studies
have explored TR as a productive ongoing process of meaning-making taking place as part of
the everyday practices of the actual researchers located at the very nexus of science and
clinic. This article therefore asks the question of how the discourse and promise of translation
is embedded and performed within the practices and perspective of the specific actors
involved. The findings are based on material from ethnographic fieldwork among translational
researchers situated in a Danish hospital research setting. The analysis draws on the ana-
lytical notion of performativity in order to approach statements and models of TR in the light
of their performative dimension. This analytical approach thus helps to highlight how the
characterizations of TR also contain prescriptions for how the world must change for these
characterizations to become true. The analysis provides insights into four different char-
acterizations of TR and reflects on the associated practices where performative success is
achieved in practice. With the presentation of these four characterizations, this paper illus-
trates different uses of the term TR among the actual actors engaged in research-clinic
activities and contributes insight into the complex processes of conceptual and material
reorganization that form part of the emergence of TR in biomedicine.
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Translational research has become subject to widespreaddebates in biomedical literature and politics, evoking highexpectations, promises, and concerns. The term “transla-
tional research” was first used in a US national cancer program in
the 90’s and has since appeared in research programs, research
strategies, academic articles and journals, policy reports, and
educational programs globally. The main interest underlying the
concept in this normative policy oriented debate derives from a
perceived series of gaps between life sciences, medical research,
clinical practices, and effects in the form of, e.g., measurable
health improvements. The rationale and promise of TR is to
ensure and encourage that public investments in health science
are turned into improved care practice and improved public
health. The term TR is used interchangeably with other terms
such as translational medicine, translational science, academic
medicine, medical knowledge translation etc. TR is closely linked
to research policy, funding incentives as well as organizational
transformation in Europe, US, Australia, and more recently the
Nordic countries, where Academic Health Science Centers
(AHSCs) have been established in recent years to encourage
translational interaction between research and clinic. As such, TR
is important as a pervasive discourse in medical science and as a
socio-economic reorganization of research practices. Existing
studies have pointed to the multiple meanings of translational
research in ongoing academic and policy debates—and to the way
in which this concept is tied to a range of varying problems and
possible solutions, not only in different medical fields but also in
different national contexts (Crabu, 2018; Greenhalgh and Wier-
inga, 2011; Krüger et al., 2018; van der Laan and Boenink, 2015).
Very few studies, however, focus empirically on how these
expectations and characterizations of TR hold true in the context
of actual researcher practices.
This article reports on an ethnographic case study of transla-
tional research networks in a Danish university hospital setting.
The investigation focused empirically on the nature of these
translational activities and on how translational research was
“made to work” in a specific research-hospital setting. This article
presents a particular sub-set of the data in order to explore how
the translational researchers themselves understood and used the
concept of translational research (TR). Focus is thus on how
actors in a Danish research setting are entangled in wider dis-
courses of TR and how they take part in performing TR dis-
cursively and materially. The analysis draws on key ideas from the
work of Science and Technology Studies in order to understand
TR as a set of performative statements and ideas that generate
their own practices and thereby create the world they describe
(Mackenzie et al., 2007; Mol, 2002). As such, the article con-
tributes empirical insights into the researchers’ own descriptions
and models regarding the concept, how the concept was per-
formed in the setting studied, how researchers engaged with the
concept, and what they made of it.
The article is structured as follows. First, I briefly present the
literature on the concept of TR. The next section presents the
methodological and theoretical backdrop for the research repor-
ted and the areas of investigation, translational research grounded
in the fields of psychiatry and oncology. Hereafter, key statements
and examples from the data are presented and analyzed. Lastly,
the discussion reflects upon TR as a complex process of meaning
production and material reorganization.
Translational research
In an important article from 2012, Van der Laan and Boenik
“disentangle” the concept and rhetoric of TR and its different
meanings, both historically and philosophically (van der Laan
and Boenink, 2015). They focus on the extensive and exponential
use of the concept in biomedical scientific literature during the
years 1993–2010 and present different epistemic dimensions
regarding the way the concept is interpreted and used. Krueger,
Hendriks, and Gauch’s more recent literature survey of the term
in biomedical and clinical research also finds a “kaleidoscope” of
different dimensions, understandings, and applications related to
the term (Krüger et al., 2018).
Despite the variances, one focal figure in this literature is the
trope of “bench to bedside”. Here, TR is a science-clinic-public
relationship conceptualized as a set of translational phases
through which knowledge moves from basic biomedical research
into diagnosis or treatment, subsequent development into
evidence-based protocols, following deployment in clinical prac-
tice, and, ultimately, benefits for the individual and society
through improvement of public health. The term implies a
relocation and translation of knowledge across what are con-
ceived of as somewhat separate domains. Yet, as noted in the
existing literature studies, the way in which the specific gaps,
models, and problematic barriers are constructed vary greatly.
Likewise, the understanding of the very domains involved differs.
Basic science, clinical research, clinical practice, the public,
society, and politics are also defined and delineated in
varying ways.
The social sciences and humanities have entered into and
contributed to the biomedical debate on translational research, as
recently reviewed by Crabu (2018). Work in these areas has
challenged the transfer notion implicitly found in much of the
literature on translational science—as well as the fundamental
distinction between basic and applied science. Qualitative
empirical studies also bring our attention to the very complex
collaborations and recursive pathways of TR, where valuable
breakthroughs in science and treatments can emerge by way of
the clinical staff and their daily questions and puzzles, from
patients or patient groups, commercial activity, or policy
demands. The creation of new medical knowledge can thus have
many “starting points” in addition to basic science, thus chal-
lenging the linearity implied in many discussions and policies on
TR. In their study of laboratory and clinical practices related to
Huntington Disease, Lewis, Hughes, and Atkinson, for example,
point to TR as a complex of clusters and multiple processes of
relocation and reconfiguration as objects, knowledge, practices,
and resources are circulated between multiple sites (Lewis et al.,
2014). Based on a study of health care innovation through
extended translational networks in Canada, Lander and
Atkinson-Grosjean (2011) likewise describe various hybrid
domains of translational science that cut across presumed divides
between basic science, clinic, as well as commercial and civic
areas. Their study also illustrates how translational pathways flow
through the interactions and relations among a complex collec-
tion of actors and organizations (Lander and Atkinson-Grosjean,
2011). This complexity is less visible in the normative depiction of
TR as a unidimensional line from basic research to clinical
practice and then to public health.
The study reported on in this paper converges with this line in
the literature located in social science and the humanities, both
openly exploring the complexities of TR and challenging the
foundations and presuppositions of a normative TR agenda. The
article focusses on the question of how actors involved in TR in a
specific research-hospital setting engage with and use the concept.
The exploration asks open questions as to which statements and
models of TR circulate among these actors? What does TR mean
in the context studied? How do these statements and models
participate in shaping research and clinical practice? How does
TR relate to other concepts and concerns? In exploring these
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questions, different understandings have emerged from the data,
summarized here as four themes: TR as knowledge flow, TR as a
political buzzword, TR as collaboration and exchange, and TR as
competency and skills. Each of these understandings is depicted
in turn in the analysis section. Based on this analysis, the paper
contributes to existing social science and humanities explorations
of TR and adds to existing work by illustrating the ways in which
the concept of TR circulates in a particular setting and how the
concept is adopted and used by actors in this setting as part of
their everyday practice. The paper argues that these performative
uses of the term are material and productive as they contribute to
organizing work, as well as attaching value to specific kinds of
work and specific skills.
The study
The study reported here is based on ethnographic fieldwork in
Danish hospitals carried out between January 2018 and March
2019. I conducted interviews and observations and collected a
broad range of organizational and project documents. Observa-
tions included research team meetings, departmental meetings,
public presentations of research, two academic conferences,
patient testing and treatment, lab visits and informal conversa-
tions (~100 h). I took hand written notes during observation and
subsequently wrote these out in text files—with concurrent
memoing. Observations and informal conversations provided
data on daily experiences and were linked to formal interviews
that were conducted in parallel (n20). Interviews were conducted
with various team members, primarily clinician-scientists (n11)
but also research team members such as Ph.D. students (n4),
biologists (n2), an engineer (n1), and lastly two department
managers (n2). The interviews lasted 1–2 h, were recorded and
transcribed with the respondents’ consent. All interviews were
conducted at the hospitals and were semi-structured and included
questions about the participants’ definitions, understandings, and
models regarding the concept of TR. Data was stored, organized,
and coded in the qualitative data analysis software NVivo using
grounded theory and analytical tools from situational analysis
(Clarke, 2005). The findings presented in this paper draw on a
sub-set of the data regarding the way in which the translational
researchers themselves understood and used the concept TR.
Ethical approval and consent were obtained in writing from the
principle investigators of the research networks and from the
informants. The project was also approved by the hospital
management and reported to the regional ethics committee.
Throughout the research project, I was simultaneously working as
a consultant in a crosscutting research and innovation support
unit at the hospitals. This involved weekly visits, meetings,
workshops, and communication with staff and management at
the hospital departments on issues related to research develop-
ment and support in the region. This concurring consultancy
work gave me a background understanding of the organization
and the research infrastructure of the hospitals, but it is not
included as a formalized part of the dataset due to research ethics
of a dual role of employee and researcher.
Oncology and psychiatry
The setting for the research here is Region Zealand in Denmark
and in particular two research networks based in the regional
hospitals. These research networks connect different research
projects or research protocols within a joint vision of changing
and improving diagnosis and/or treatment within two very dif-
ferent medical areas, child and youth psychiatric diagnosis and
cancer treatment. The two translational research networks were
interdisciplinary, yet anchored in the two domains of oncology
and psychiatry, referred to here as the electroporation and autism
networks. The electroporation case was an international colla-
borative network working to develop and improve a new type of
treatment for cancer, electroporation. This technique creates an
electrostatic field in cancer cells in order to increase the perme-
ability of the cell membrane, allowing chemicals, drugs or DNA
to be introduced into the cell. When applied locally, this type of
treatment has been found effective in killing the cancer cells of the
tumor, and the treatment with this technique combined with
administering calcium was found to release patterns into the
immune system, possibly hindering a recurrence of the tumor
and slowing further spreading of the cancer. A range of related
projects sought to refine the technique in relation to specific
cancer types and in relation to different types of chemicals, and to
explore systemic immune responses of the treatment found
clinically as an unexpected outcome of the treatment. This net-
work played an important role in developing and implementing
this particular type of cancer treatment internationally. The group
was involved in developing European guidelines for clinical
practices and in various political and practical implementation
efforts to establish the treatment type as part of the standardized
treatment program for specific cancer types in Denmark. The
researchers were thus deeply engaged in research, but they were
also focused on realizing its application in the clinic. Most of the
researchers were also responsible for everyday clinical practices of
examining patients and determining treatment strategies.
The second research network I studied conducted research on
autism disorders in children and youth through a translational
research design combining behavioral, psychological, and neu-
robiological approaches. The project was situated within a
broader disciplinary debate regarding the Diagnostic and Statis-
tical Manual (DSM) and concerning controversies as to the way
in which to categorize symptoms of mental disorders. Autism in
particular presents a contested diagnostic category, appearing
clinically in a variety of forms and with varying professional
understandings of its nature and appropriate treatments. The
research network was concerned with this broader questioning of
the very notion of autism as a singular disorder category and was
critical of current diagnostic criteria and classification. Further-
more, the research network formed part of a shift in the clinic and
the field more generally towards investigating mental disorders
such as autism through laboratory practices and technologies like
new IT-based cognitive function testing, electroencephalography
(EEG), and magnetic resonance imaging (MRI). The researchers’
work was exploratory, seeking to find new ways of understanding
autism as both symptoms and pathology, e.g., through a key
psychiatric concept of cognitive flexibility that was investigated as
part of the project.
Although several of the projects within both of these research
networks included industrial partners, the lead researchers
themselves stressed that their research was “investigator-initiated”
and thus different in nature from clinical trials and medical
research driven by industry. The lead researchers themselves
framed their research, the research designs and approaches, as
“translational”, e.g., in presentations and funding applications
(“translational forskning” in Danish).
Analytical framework
Science Studies, Feminist Theory, and Cultural Studies have
explored empirically and theoretically the way in which discourse,
statements, and representations have productive consequences
and effects upon reality (Foucault, 1990; Haraway, 1988; Latour,
1987; Mol, 2002). In their book on economics, Mackenzie et al.
(2007) develop the term performativity to examine how economic
theory takes part in shaping economic realities—how statements,
models, concepts, and formulas over time shape the very worlds
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they describe. These authors illustrate how reality—socially and
materially—over time becomes reshaped to fit with theoretical
models and inherent presumptions. This analytical lens is highly
relevant for understanding how the language of TR has been, and
continually is, an agent for modifying the reality it describes. This
analytical lens also leads us to study how actors involved in TR
research take part in the actualization and “putting into motion”
of TR through their use of TR concepts, models, and research
designs. This is the focus in the following analysis where sig-
nificant examples and excerpts related to the use of TR termi-
nology are presented and discussed. According to Mol (2002),
conversations and interviews are a way of listening to informants
as if they were their own ethnographers, telling how their work of
TR is understood and carried out. Interviews and conversations
are thus analyzed as a way of learning about objects, events, and
practices that are material and productive.
Analysis
The analysis is organized according to four main understandings
emerging from the data—TR as knowledge flow, TR as a political
buzzword, TR as knowledge collaboration and exchange, and TR
as competencies and skills. The quotes and excerpts are anon-
ymized with regard to informant names and field of expertize and
only attributed to the research network—named here as the
autism and electroporation network, respectively. Throughout the
analysis, the two networks also serve as analytical prisms for one
another, juxtaposing their similarities and differences.
TR as knowledge flow from theory to practice. During the
study, a dominant understanding of TR that appeared during
observations, informal conversations, and interview questioning
on the topic was TR as knowledge flow from theory to practice.
This understanding aligns with the notion and modeling of TR
that is pervasive in biomedical literature and the aforementioned
bench to bedside trope. TR is conceived of as a set of transfers or
flows of knowledge from basic biomedical research into clinical
diagnosis and improved health for patients—and also concerns
closing the gaps hindering this flow. This understanding was
particularly prevalent in the electroporation network. A lead
researcher involved in setting up laboratory studies, clinical trials,
and implementation efforts in relation to the treatment technique
electroporation explains her understanding of translational
research to me in an interview:
It is about closing the gap between lab research and the
patient’s everyday life. Moving knowledge from the
laboratory over into clinical practice, as well as ensuring
how we can take the biological tests that afterwards can go
back to the researchers… moving from idea, to laboratory
research, to clinical research and all the way into guidelines
for new treatment. (Electroporation network)
This quote resonates with the dominant understanding of TR
as knowledge that flows through a set of otherwise separate
contexts and knowledge domains framed as laboratory, clinical
practice (with associated guidelines), and the patient’s everyday
life. She describes TR as the moving of laboratory research into
clinical practice, and how TR also produces the biological data in
the clinic to move back into the lab.
At a research event and presentation at the hospital, this
researcher presents a timeline of her research on electroporation.
She explains how she has been involved in the basic science in
order to understand the cells and cell membranes and how they
can be briefly destabilized by applying electrical pulses to the area.
Based on these insights into cellular behavior, they developed new
experimental electro-engineering tools for applying electricity
directly to the skin and tumor and then for injecting drugs and
chemicals into the area so these can enter into the tumor and cells
creating a local and very effective new treatment form. These
tools have subsequently been refined and developed and are part
of standard treatment regimes for specific types of cancer, such as
skin cancer. In addition, the technique and technology are being
developed further for other types of cancers. For example,
stomach and colon cancer, where the tumor is more difficult to
access directly with electrodes. Here, the electrodes were under-
going further development in order for them to work with
endoscopic devices.
In a timeline figure, a presentation slide sketches the steps of
translation from basic science over into techniques tested on mice
in order, for example, to refine how to administer the electricity
and chemicals in an appropriate way and with the correct
dosages. This led to further experimental treatments on patients,
and later on, randomized trials with a larger number of patients
proving both the safety and efficacy of this specific type of
treatment. In 2013, the UK National Institute for Health and Care
Excellence (NICE) guidelines state that sufficient evidence has
been established for this particular treatment for cancer spreading
in the skin. In conclusion, she notes that this process has been a
relatively “rapid process of translation from the first discoveries to
a treatment in widespread use.” She moves on to explain their
more recent work on using calcium with this type of treatment to
determine how this might have effects upon the immune system
beyond the local effects of cancer cell death. The timeline and
story of electroporation reiterates a temporal TR image of
knowledge flow from theory to practice—and back again—
over time.
When asked about definitions of the term translational,
another researcher, part of the oncology research networks but
involved in the study and treatment of other cancer types,
similarly notes:
I think translational covers when we turn over basic science
into practical science. I see it as research where we get out
and onward from the lab. We have an aim that is out of the
lab, and it is important for us to do something that
potentially can get out and work in society. (Electropora-
tion network)
This quote links up to an understanding of making science
applicable and “something that can be used.” Other informants
likewise recognized TR as the clinical application of theoretical or
experimental knowledge—or “moving new knowledge closer to
the clinic, so “it can be used and tested further.” One informant
notes that TR in this way consists of a practical achievement that
moves theory into clinical practice:
I define translational as the clinical application of
theoretical or experimental knowledge. So translational
science is that one translates, really a utilitarian term, that
you translate something proven ex vivo or proven in a petri
dish to something that has clinical consequences for
patients.” (Electroporation network)
In the accounts recorded during the study, an understanding of
TR as knowledge flow from theory to practice thus is in
agreement with the dominant discourse in the literature and
“promise of translation” envisioned in the future (Brown et al.,
2000). The hope is that public investments in health science can
and should be paid back in the form of improved care practice
and improved public health. “Making a difference” was often
mentioned as motivation for the career choice of working with
translational hospital-based research, along with the value of
participating in research that might be practically applicable to
and an improvement of current clinical practice. This applicable-
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practice motivation was notable in both the electroporation and
the autism network.
Following Mackenzie et al. (2007), the accounts and ideas also
speak of actual practices where, in the electroporation network,
knowledge artefacts, as well as biological material are relocated
and exchanged. There are also accounts of how experimental
research is connected to changing procedures for cancer
treatment strategies and new standardized treatment programs.
TR as a political buzzword. Several of the informants in both
research networks noted the buzzword character of the word,
smiling or laughing at my question of their understanding in the
interview thereby distancing themselves from the concept and
instead locating the concept in a world of politics and funding
bodies with interests different from their own. They reiterated
statements resembling the objectives discussed above regarding
knowledge flow and transfer, but then added that these ideas did
not necessarily match the way TR projects actually played out
according to their experience. A researcher from the autism
network notes:
I know what it means, but that is not how I see it
implemented. It is research that supposedly builds bridges
between experimental research… over into clinical
research, maybe back again. However, when I see transla-
tional programs implemented, it does not really get out to
the patients, and it does not really get out into the clinic.
(Autism network)
Several informants noted that the TR had a political buzzword
quality and was about justifying funding for very specific types of
research. Therefore, for some there was a discrepancy between
the rhetoric of TR and the way it was realized in ongoing
projects. Accounts such as the above imply a critical position—
that the translational agenda is a way of living up to demands of
funders or creating political enthusiasm for research—but that
the actual move into clinic and patient benefits could be
questioned.
One informant described TR as a specific kind of research
funding to expand “the evidence base” rather than research
enabling knowledge to flow between basic science and the clinic.
Really, a buzzword is about creating the funding to make
the evidence. It is relatively inexpensive to fund the small,
experimental studies but gets expensive when you want to
test an intervention on a larger group. It is complicated to
create the evidence to prove that this really should be part
of the standard treatment plan. So it is a way of creating
funding for this difficult phase, where promising research
needs to create the evidence base for it to get used.
(Electroporation network)
Here, TR is a way of creating political support for particular
types of research funding—a way of filling an evidence gap that is
necessary for something to be legitimate and justifiable as a
diagnostic or treatment option in the clinic. Thus, in this
understanding TR is understood as a rhetorical device serving
particular interests and political agendas. This resonates with the
political move to put significant resources into TR to increase the
clinical relevance and application of research. Using research
relies on the creation of very specific types of “robust” evidence
such as randomized controlled trials—and these are a necessary
intermediate stage for research findings to reach decision-makers
and potentially have societal health impacts. So here, TR is about
the political support for specific types of research, for creating
particular research infrastructures that can enable credibility,
validity, and paths of impacts for medical research.
Conversations and interviews where TR was referred to as a
political buzzword can also be seen as part of the actors’ own
reflections on a broader knowledge economy where colleagues, or
they themselves, attempt to position themselves strategically in
relation to political and funding agendas. They adhere to, draw
on, but also smile at this—since what they see “play out”
sometimes is a different scenario. The actors in both research
networks involved were thus attentive to how one as a researcher
strategically can link up to political agendas and adjust projects so
they match the demands of policy and funding trends. Here, TR
is pointed to as rhetorically powerful in justifying specific types of
research resonating related analyses of how TR currently is
mobilized in other national academic medical settings (Rushforth,
2016; Wilson-Kovacs and Hauskeller, 2012).
TR as interdisciplinary collaboration and exchange. A third
understanding of TR that appeared in both networks was TR as a
framing of interdisciplinary collaboration. Models and research
designs of TR enabled and encouraged collaborations and
exchanges across different medical specializations and across
distinct departments and organizations. A researcher from the
autism research network replies to the question of how she
understands the term translational as follows:
I understand it broadly, that you try to connect knowledge
and understanding from different levels—psychological,
biological, social etc.—into a joint understanding of a
phenomenon… The same phenomenon might really be the
result of many different processes. (Autism network)
She moves on to explain how such processes can be captured at
different levels and through different investigational methodol-
ogies deriving from different disciplines. Methods in her project
included preclinical and clinical testing, neurobiological
approaches, brain imaging, and at a later stage, if the funding
becomes available, possibly also genetic testing. She explains that
a translational approach is the next step in developing new
knowledge on autism. Here, the promise of TR is to connect
different knowledge forms to create radically new understandings.
The idea here is that the translational can dismantle
diagnoses, as they are today. If we understand the
translational levels, we will understand that the diagnostic
system and the psychiatric system should be put together
differently. (Autism network)
The research design of the autism project is therefore organized
around a translational model that the lead researcher sketches for
me on the whiteboard in her office, and later, after the interview,
she sends me the model figure used in applications and when
presenting the research (Fig. 1). Here, different translational levels
are depicted along with the examinations, methods, and
procedures applied to produce knowledge about these levels.
The research project is designed around these translational levels
through which the children included in the study move during a
series of examinations marked in the figure as “assessments 1–5”
under the column with procedures, ranging from standardized
clinical screening tests and questionnaires, IT-based cognitive
tests and paraclinical methods, including electroencephalography
(EEG) and magnetic resonance imaging (MRI). These methods
provide knowledge on different translational levels from the
“psychosocial down to something increasingly biologically based”,
she explains.
The model organizes the research project, the series of tests and
examinations the patients and control subjects go through in
which different kinds of technologies and expertize are involved.
The tests take place in the childrens’ homes and in their school
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settings (using standardized questionnaires filled out by parents
and teachers), in the psychiatric clinic (again using standardized
screening and new cognitive tests developed as part of the
project), in a neurobiology lab at the neurology department and
at the department of medical imaging (where the MRI scanning
technologies are located). The studies require personnel and
expertize from these various disciplines in order to carry out the
examinations and analyze the results. The autism research
network thus spanned different departments and disciplinary
specializations of child and youth psychiatry, psychology,
psychophysiology, radiology, neurology, engineering, and screen-
ing software/IT development.
“It is like we take a cross-section and look at the same
phenomenon at different levels”. (Autism network)
The translational research design brings together different
methods and techniques for investigating many different
parameters associated with autism. In this sense, the model of
the translational research design can be seen as a workable
boundary object (Star and Griesemer, 1989) enabling collabora-
tion across a complex of scientific inquiry methods and
knowledge forms into a joint workable research design. The
model helps to make possible collaboration across specializations
and departments and facilitates a joint study that combines
approaches where autism is framed in different ways: as related to
social, behavioral, and clinical symptoms, as a disease with a
possible neurological basis, and as a disease with a possible brain
structural basis. Through the translational research model, it
becomes possible to relocate the phenomenon of autism into
different disciplines and as such offers a tool towards collabora-
tion. The language of TR in the autism network can thus be seen
as a contact language enabling a joint interdisciplinary project to
be planned and agreed upon (Galison, 1999).
In the same way, projects within the electroporation network
were framed and depicted in translational models and research
designs. This network also involved collaboration between a range
of disciplines and areas of expertize, requiring collaboration
between researchers based in oncology, surgery, dermatology,
pathology, biochemistry, molecular biology, immunology, phy-
sics, engineering, IT, and palliation. A model (Fig. 2) was used in
a research presentation to depict and present a subproject taking
place within this translational network. The project was set up as
a collaboration between the oncology and surgery department at
the Danish hospital and included several other partners such as
universities, industry, and e.g., a leading immunological research
institute in France working to develop new methods to
characterize the immune characteristics of cancer tumors, “the
cellular landscape of the tumor”. Like the model from the autism
network, it looks “across” and combines different types of
examination and methodologies in a new way.
One of the lead researchers explains the translational set-up for
the study in which the patient is treated with calcium
electroporation before the planned surgical removal of a cancer
tumor. The treatment prior to surgery aims to stop the tumor
growth and hinder spreading of the cancer. Blood samples and
tumor biopsies are taken, and biological data is recorded before
and after the surgery to assess the effect of the intervention. In the
boxes on the left, the figure presents the different stages of cancer
development to be examined—early cancer, advanced cancer, and
cancer that has spread in the body (metastasized). The
investigations then focus on three ways of “reading” the
intervention. Firstly, what happens to the patients? Is it safe?
How is the treatment experienced by the patient, e.g., pain? Are
the side effects short term and long term? Does the tumor grow or
spread (as seen and measured through imaging technologies)?
Secondly, what happens as the result of this treatment at the
molecular level in the tumor and in the blood, examined through
Fig. 1 Translational model autism. The translational model was shared by
an informant in the autism research network and derives from their project
description. The model depicts different translational levels along with the
examinations, methods, and procedures applied to produce knowledge
about these levels. The research project is designed around these
translational levels and a series of examinations marked in the figure as
“assessments 1–5” under the column with procedures, ranging from
standardized clinical screening tests and questionnaires, IT-based cognitive
testing, electroencephalography (EEG) to magnetic resonance
imaging (MRI).
Fig. 2 Translational model electroporation. The translational model was
shared by an informant in the electropration research network and derives
from their project description. The model depicts the translational set-up
for the study and different methods for examination that include and “sum
up” patient outcomes, blood samples, and tumor biopsies across different
stages of cancer—early cancer (Tidlig colon og rectum cancer), advanced
cancer (Lokal avanceret rectum cancer), and cancer that has spread in the
body (Metastatisk sygdom).
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tumor biopsy investigations and blood profiling testing before
and after the treatment intervention? These different “readings”
of the interventions’ effects are summed up (+). The researcher
explains that this can be a new way of producing knowledge
about the variation they find clinically, for example of how the
same intervention works differently in two patients, by looking at
the cellular level and the biological markers to explain and
understand the variation and the immunological changes
involved. Translation is a way of making the effects of an
intervention visible and documentable, as a way of proving a link
between treatment and specific effects. As such “translational” is a
set of methods and tools that can be used to compare and
evaluate treatments with the potentiality of providing a new and
different kind of knowledge of what works, and sometimes how
it works.
In the electroporation network, several researchers noted that
the research is fragmented and separate (e.g., in relation to the
different stages of cancers or in relation to different treatments
before or after surgery). A researcher explains that not a lot of
research focuses on all three phases, but that looking at the
immune system as a whole rather than the tumor as an isolated
entity to be treated or removed is often neglected. Looking at the
effects of the treatment overall requires what he notes as a
“helicopter view”. Another researcher in the project similarly
refers to this work as grasping the “bigger picture”.
It is about designing the study so you see the bigger picture
and get a 360-degree view… If you want to make a
difference and do research that moves the way we think,
then you have to include all the parts and include the whole
spectrum. (Electroporation network)
Ideally, for example, results from patient-reported outcomes,
molecular biological examinations of blood samples and immu-
nological investigations of tumor material are linked up in the
research project—as are different stages of cancer and phases of
cancer treatment like pre, during, and post operation, thereby
encompassing the “whole spectrum” by working across dis-
ciplines and joining differing techniques and niches of research.
For both networks, bringing together these different investiga-
tional techniques and methods was where the research had the
break-through potential to be a “game changer”, as one researcher
puts it—in the sense of a new way of thinking about cancer or an
entirely new approach to psychiatric diagnosis. This is where
there is a promise and potential to change the foundations for
existing classifications, diagnostics, and treatment strategies of
illnesses. In both networks, TR is a productive and adaptable way
of framing interdisciplinary research and multifaceted research
problems. TR holds a promise of not only creating usefulness of
research, but also of changing fundamental paradigms of both
clinical research and practice.
TR as competencies and skills. A final and fourth under-
standing reappearing in the data material is TR as compe-
tencies and skills. When explaining their TR understandings
and research activities it was often noted by the informants
that such work required a set of specific competencies and
skills. This concerned the ability to develop and use transla-
tional tools and methodologies in the research project and at
the hospital. In the excerpt below, a lead researcher stresses the
aspect of “ability to use”:
“To me, translation is the ability to have a tool to
translate an effect of something, a clinical intervention, a
clinical problem—to be able to translate that into an
effect on the genetic, cellular, or molecular level. So
translation to me is using that methodology, that
method, to find an effect of something that happens
clinically.” (Electroporation network)
As part of the electroporation study, Ph.D. students and
young researchers went abroad and participated in research
courses, seminars and visits—one in an electro-engineering
institute in Slovenia to learn the electrophysics behind the
technique, the other in an immunology laboratory in France to
learn how to measure immune cells in the tumor with a novel
prognostic technique. These kinds of exchanges were vital to
developing the skills necessary to realize the TR objectives of
the project. One of the Ph.D. students explains this as
somewhat different from other kinds of clinical research at
the department.
When you are a researcher at a hospital, you stand there
with your patient, and then you send off your tests, I have
heard jokes about this in the lab, you send off your tests
into a black box, and we get a bunch of numbers back. I
would like to go into that black box and see what happens,
to understand how the tests are practically handled in the
lab, because I think that the very numbers I get out of that
black box, well I will to a greater degree understand them, if
I have been there in the lab, where I see it and have it in my
hands. (Electroporation network)
In this quote, the physician in research training points to her
own movement between research located in a clinic and in a
laboratory. Part of her research plan is to move into the
laboratory and acquire the skills to understand laboratory-based
analysis, results and possibilities. In order to gain these skills and
competencies, and apply them to the clinical focus of her
research, she notes how it is necessary to physically “move into
the black box” and “have it in my hands”. As such, her training
involves a shift from more “traditional” medical research into a
new kind of translational research.
Another team member in the project has a background in
human biology. She has been hired to support the translational
research at the department and highlights that it is the exchanges
between the different professional groups in the project that are
so necessary and where we “really make the most of the
knowledge we have”. She explains her mediating work and role
and how her educational background in human biology has
equipped her to be a clinical research biologist.
It is really about understanding a little bit of everybody
else’s areas or field, so you can be precisely that link
between chemists, physicists, and doctors. (Electroporation
network)
In the electroporation network, a TR research agenda was thus
closely linked with recruiting or educating the “TR agents” that
could facilitate research activities and exchanges across dis-
ciplinary boundaries. A crucial supporting aim of the TR
networks was thus to develop these skills in house—at the
department and at the hospital, rendering the opportunities in the
technologies and the lab more accessible.
Likewise, Ph.D. students in the autism network were trained
thoroughly in the working of the neuro-lab by experts at the
hospital and from abroad, setting up and using the physical
equipment for carrying out EEG examinations, as well as the
technologies and software involved in data analysis of the EEG
results. As noted by one of the Ph.D. students, this was really a
very different set of “much more technical skills” than those he
was trained in as medical doctor in child and youth psychiatry.
A key participant in the autism network was for example a
trained psychologist and had experience from a previous job
with MRI brain scanning techniques. His expertize in both
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child and youth psychiatry and imaging technologies made it
possible to connect the psychiatric research interests with
possibilities in the MRI devices for testing and analysis. He
could speak the necessary highly specialized language related to
diagnostic imaging, such as multi-slicing, pulse-sequences, and
fiber tracking etc. He enabled the interactions and exchanges
among the psychiatrists and the MRI engineer and imaging
professor. Such ability to apply new methodologies across
disciplines and to converse and move expertly across more than
one discipline is thus a fourth way in which the discourse and
promise of translation was embedded within the practices of
both research networks.
Discussion
This article has presented and explored different uses of the TR
terminology in two specific settings of biomedical clinic-academic
work practices. This type of inquiry is underexplored in the lit-
erature, and this empirical contribution thus adds to related
efforts into studying how the actors in the field respond to
political agendas of TR and changes in the biomedical research-
clinic landscapes (Rushforth, 2016; Vignola-Gagne, 2014; Wilson-
Kovacs and Hauskeller, 2012). The analysis has put forth a set of
performative statements on TR along with the models of trans-
lation presented by these actors. Here we see how TR is
embedded in the practices and perspectives of a set of particular
actors involved in TR.
The first characterization of TR as knowledge flow can be
viewed as an adaptation of the normative language of TR
debates and policies. The goal and value of bench to bedside
work enters into the actors’ own characterizations and
meaning-making of their everyday work—as it also produc-
tively shapes and organizes these practices. Researchers
involved in TR take on and seek to fulfill expectations and
visions of the TR discourse and assumptions that circulate
among funders, evaluators, management, and in health care
prioritization and politics. TR also becomes part of the actors’
own sense-making and vision of how value can be created
through their work for patients and for society. This brings our
attention to how actors involved in carrying out TR take part
in actualizing and putting into motion theories, models, and
the very propositions of TR. This characterization places
positive value upon specific kinds of work in the hospitals and
among the hospital-based researchers. Translational research
work that can ensure that research results are used, integrated
into practice, and can produce benefits for patients and society
is thus also characterized and performed as desirable and good.
The second characterization points to the critical position of
TR as associated with a political agenda and something that can
be used strategically to secure funding. TR offers an opportunity
for researchers to position themselves advantageously in relation
to TR policy and funding—thus potentially gaining a privileged
professional status as key leaders of change, as noted in related
studies (Vignola-Gagne, 2014; Wainwright and Williams, 2009;
Wilson-Kovacs and Hauskeller, 2012). The researchers them-
selves take part in critically reflecting upon political agendas,
funding flows and the consequences for their work, their career,
and their field of expertize. They thus participate in questioning
the very promises and hopes of the TR dominant discourse and
the transformations they experience.
In the third characterization presented here, TR as collabora-
tion and exchange, TR becomes a way of seeing and analyzing the
subject matter across disciplinary divides. As such, the transla-
tional research design combines several different investigational
methodologies from different and otherwise somewhat distinct
disciplines. In the terms of Latour, these techniques mediate the
object studied in different ways, rendering it visible for science in
particular ways (Latour, 1987), and these different mediations are
brought together in the promise of “seeing the bigger picture”—
and “changing the game” in radical ways. TR discourse and
promises become an organizing factor for research and research
activities in the hospital studied. TR serves to facilitate episte-
mological boundary spanning (Evans and Scarbrough, 2014) and
is a productive way of framing interdisciplinary research and
multifaceted research problems that cannot be solved with tra-
ditional research frameworks. In this understanding TR perhaps
opens for alternative ways of creating medical knowledge and
evidence other than—or in combination with—the gold standard
of randomized controlled trials (Timmermans and Berg, 2003;
Wieringa et al., 2017).
Lastly, TR is closely linked to the building and expanding of
interdisciplinary and transactional skills in the hospital setting
studied. This is discussed under the fourth characterization, TR as
competencies and skills. This theme highlights the integration of
new knowledge forms into the hospital research setting, as well as
the very practical, material, and embodied abilities of TR such as
handling the equipment, delivering the electric pulses to the
tumor areas as in electroporation, and learning to administer the
details of the EEG equipment and devices. New skills must be
learned and entered into clinical practice and experimentation.
Likewise, medically trained employees move into the lab and
learn to work with the biopsies, blood samples, and cells “in their
hands”. Scientific investigation of cancers and autism is shifted
out of the clinic into the laboratories of for example neurobiology
and brain imaging—and the techniques and skills from these
disciplines are relocated into clinical and medical practice and
achieve new value here.
With the presentation of these four understandings, this article
illustrates different uses of the term TR among actors engaged in
research-clinic activities in two settings, that of clinical oncology and
that of clinical psychiatry. The analysis presented in this article does,
of course, not cover all the ways in which actors involved in TR use
the term. Rather it illustrates some specific, situated uses—uses that
reappeared and were focal in the data material produced in this
study. The analysis provides new insights into TR as a”force of
example” (Flyvbjerg, 2006). Rather than providing a total overview
or mapping generalized patterns, the analysis explores specific
context-dependent appearances of TR. The study brings out differ-
ences and connections for further juxtaposition to other studies in
different specializations in different national contexts. It is important
to note that the characterizations were not mutually exclusive, but
overlapping and entangled in the setting studied. The under-
standings were mobilized, in turn, to bring out different aspects and
values of the hospital-based research work in specific situations. All
characterizations circulated in both networks—thus seemingly co-
existing within these networks, as well as sometimes in the course of
a single interview.
Notable are however also some of the differences in the two
research networks. The networks were not analyzed as com-
parative cases (several cases of the same), but selected due to
differences and analyzed in juxtaposition to bring out differences.
In the electroporation network, the dominant understanding of
TR as knowledge flow was more prevalent than in the autism
network. In the electroporation network TR as knowlegde flow
appeared as the primary understanding of the term and also as an
important guiding rationale of conducting hospital-based trans-
lational research. This might be linked to the ways in which the
field of cancer research historically has been tied to the political
and funding agenda of TR. Historical studies have analyzed how
the rise of translational research and a translational agenda,
particularly in the US, is closely linked to cancer research and to
the promise of cancer cures based on research into new drugs and
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treatment therapies (Fujimura, 1996; Keating and Cambrosio,
2012; Löwy, 1996). All early publications 1992–1997 using the
term are also related to cancer research, in particular research on
biomarkers in relation to cancer prevention and the establishment
of tissue banks and cancer research centers in this period (van der
Laan and Boenink, 2015). Historically, TR in this version seems
more closely linked to the electroporation network than to that of
psychiatry—where the understanding of TR as collaboration and
exchange was foregrounded more often. These differences bring
our attention to the ways in which TR is situated differently in
different disciplines and underscores the contextual nature of the
concept.
Conclusion
This article has presented selected findings from an ethnographic
study of the everyday practices of TR in a specific setting. The
discourse of TR, including the policy initiatives and organiza-
tional transformations linked to the TR discourse, can be seen as
a paradigmatic shift in medical science. Yet little is known about
how such a paradigm shift plays out in concrete settings, what it
means to the actors involved, how it changes what constitutes
meaningful and valuable research—as well as meaningful and
valuable everyday work practices. This article proposes that actors
take part in performing the emergence of TR and possible
paradigm shifts by foregrounding and valuing specific versions of
TR along with specific practices, specific skills. This entails that
other practices and skills perhaps are backgrounded and become
less visible and less valued. That which the less visible and less-
valued practices are composed of (e.g., perspectives of patients or
other working groups at the hospitals) constitutes a pressing
question for further work beyond the scope of this paper. One of
the important points highlighted here is the different ways in
which TR discourses, promises, and expectations form an active
part of the researchers’ sense-making and practices. The analysis
presented in this article also allows us to reflect on how these
actors take part in fulfilling a societal obligation, encouraging and
improving the clinical application and clinical benefit of new
scientific knowledge. They share the concerns found in the TR
debates and policy regarding the closing of a “bench-to-bedside
gap”, but also rework these orientations in relation to their spe-
cific projects and practices. Applying the notion of performativity,
statements and models of TR have been approached in the light
of their agency and their performative dimension. This analytical
approach thus helps to understand how TR characterizations—
and statements—also contain a prescription for how the world
must change for them to become true. Mackenzie et.al. suggest
that performative success is when there is created both a new
language and theory, as well as new reality (2007). This article
provides insights into four co-existing characterizations where
such performative success was achieved in the setting studied.
The analysis also points to a disciplinary difference through the
juxtaposition of two different research networks. New languages,
theories and realities were successfully in the making in these
networks along with changing implications for the way in which
research knowledge is produced and applied, as well as cultural
shifts in what constitutes good and valuable research. In con-
clusion, this performative lens is proposed as a potential step
forward toward developing a social science and humanities
understanding of TR, how usefulness of research is characterized
and realized through practice while keeping in sight the com-
plexity and materiality of such processes.
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